Blood-neural barrier: Its diversity and coordinated cell-to-cell communication

Journal of Biochemistry and Molecular Biology

Volumn 41, Issue 5, 2008, Pages 345-352

  Yoon, Kyung Choi ^a   Kim, Kyu Won ^a  

^a Seoul National University   (South Korea)

Author keywords

Barriergenesis; Blood neural barrier; Cell to cell communication; Cerebrovascular disorders; Neurovascular unit

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; BLOOD BRAIN BARRIER; BLOOD NERVE BARRIER; CARDIOVASCULAR SYSTEM; CELL COMMUNICATION; CEREBROVASCULAR DISEASE; CYTOLOGY; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SHORT SURVEY;

ANIMALS; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; CARDIOVASCULAR SYSTEM; CELL COMMUNICATION; CEREBROVASCULAR DISORDERS; HUMANS; MODELS, BIOLOGICAL;

EID: 44849099528     PISSN: 12258687     EISSN: 02191024     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (53)

1. Garcia, C. M., Darland, D. C., Massingham, L. J. and D'Amore, P. A. (2004) Endothelial cell-astrocyte interactions and TGF beta are required for induction of blood-neural barrier properties. Brain Res. Dev. Brain Res. 152, 25-38.
2. Neuwelt, E., Abbott, N. J., Abrey, L., Banks, W. A., Blakley, B., Davis, T., Engelhardt, B., Grammas, P., Nedergaard, M., Nutt, J., Pardridge, W., Rosenberg, G. A., Smith, Q. and Drewes, L. R. (2008) Strategies to advance translational research into brain barriers. Lancet Neurol. 7, 84-96.
3. Lee, S. W., Kim, W. J., Choi, Y. K., Song, H. S., Son, M. J., Gelman, I. H., Kim, Y. J. and Kim, K. W. (2003) SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat. Med. 9, 900-906.
4. Lindahl, P., Johansson, B. R., Leveen, P. and Betsholtz, C. (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245.
5. Sugiyama, Y., Kusuhara, H. and Suzuki, H. (1999) Kinetic and biochemical analysis of carrier-mediated efflux of drugs through the blood-brain and blood-cerebrospinal fluid barriers: importance in the drug delivery to the brain. J. Control. Release 62, 179-186.
6. Zhang, Y., Porat, R. M., Alon, T., Keshet, E. and Stone, J. (1999) Tissue oxygen levels control astrocyte movement and differentiation in developing retina. Brain Res. Dev. Brain Res. 118, 135-145.
7. Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan-Ling, T. and Keshet, E. (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738-4747.
8. Choi, Y. K., Kim, J. H., Kim, W. J., Lee, H. Y., Park, J. A., Lee, S. W., Yoon, D. K., Kim, H. H., Chung, H., Yu, Y. S. and Kim, K. W. (2007) AKAP12 regulates human blood-retinal barrier formation by downregulation of hypoxia-inducible factor-1alpha. J. Neurosci. 27, 4472-4481.
9. West, H., Richardson, W. D. and Fruttiger, M. (2005) Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes. Development 132, 1855-1862.
10. Mautes, A. E., Weinzierl, M. R., Donovan, F. and Noble, L. J. (2000) Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys. Ther. 80, 673-687.
11. Sharma, H. S. (2005) Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr. Pharm. Des. 11, 1353-1389.
12. Pan, W., Banks, W. A. and Kastin, A. J. (1997) Permeability of the blood-brain and blood-spinal cord barriers to interferons. J. Neuroimmunol. 76, 105-111.
13. Juhn, S. K., Hunter, B. A. and Odland, R. M. (2001) Blood-labyrinth barrier and fluid dynamics of the inner ear. Int. Tinnitus J. 7, 72-83.
14. Steyger, P. S., Peters, S. L., Rehling, J., Hordichok, A. and Dai, C. F. (2003) Uptake of gentamicin by bullfrog saccular hair cells in vitro. J. Assoc. Res. Otolaryngol. 4, 565-578.
15. Kitajiri, S. I., Furuse, M., Morita, K., Saishin-Kiuchi, Y., Kido, H., Ito, J. and Tsukita, S. (2004) Expression patterns of claudins, tight junction adhesion molecules, in the inner ear. Hear. Res. 187, 25-34.
16. Wilcox, E. R., Burton, Q. L., Naz, S., Riazuddin, S., Smith, T. N., Ploplis, B., Belyantseva, I., Ben-Yosef, T., Liburd, N. A., Morell, R. J., Kachar, B., Wu, D. K., Griffith, A. J. and Friedman, T. B. (2001) Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell 104, 165-172.
17. Rechthand, E. and Rapoport, S. I. (1987) Regulation of the microenvironment of peripheral nerve: role of the blood-nerve barrier. Prog. Neurobiol. 28, 303-343.
18. Wadhwani, K. C. and Rapoport, S. I. (1994) Transport properties of vertebrate blood-nerve barrier: comparison with blood-brain barrier. Prog. Neurobiol. 43, 235-279.
19. Leveen, P., Pekny, M., Gebre-Medhin, S., Swolin, B., Larsson, E. and Betsholtz, C. (1994) Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8, 1875-1887.
20. Sundberg, C., Kowanetz, M., Brown, L. F., Detmar, M. and Dvorak, H. F. (2002) Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab. Invest. 82, 387-401.
21. Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L., Croll, S. D., Glazer, N., Holash, J., McDonald, D. M. and Yancopoulos, G. D. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6, 460-463.
22. Pepper, M. S. (1997) Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 8, 21-43.
23. Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S. and Akhurst, R. J. (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121, 1845-1854.
24. Gerhardt, H., Wolburg, H. and Redies, C. (2000) N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken. Dev. Dyn. 218, 472-479.
25. Mi, H., Haeberle, H. and Barres, B. A. (2001) Induction of astrocyte differentiation by endothelial cells. J. Neurosci. 21, 1538-1547.
26. Nishino, J., Yamashita, K., Hashiguchi, H., Fujii, H., Shimazaki, T. and Hamada, H. (2004) Meteorin: a secreted protein that regulates glial cell differentiation and promotes axonal extension. EMBO J. 23, 1998-2008.
27. Park, J. A., Lee, H. S., Ko, K. J., Park, S. Y., Kim, J. H., Choe, G., Kweon, H. S., Song, H. S., Ahn, J. C., Yu, Y. S. and Kim, K. W. (2008) Meteorin regulates angiogenesis at the gliovascular interface. Glia 56, 247-258.
28. Vailhe, B. and Feige, J. J. (2003) Thrombospondins as anti-angiogenic therapeutic agents. Curr. Pharm. Des. 9, 583-588.
29. Reuss, B., Dono, R. and Unsicker, K. (2003) Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood-brain barrier permeability: evidence from mouse mutants. J. Neurosci. 23, 6404-6412.
30. Pekny, M., Stanness, K. A., Eliasson, C., Betsholtz, C. and Janigro, D. (1998) Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice. Glia 22, 390-400.
31. Igarashi, Y., Utsumi, H., Chiba, H., Yamada-Sasamori, Y., Tobioka, H., Kamimura, Y., Furuuchi, K., Kokai, Y., Nakagawa, T., Mori, M. and Sawada, N. (1999) Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem. Biophys. Res. Commun. 261, 108-112.
32. Christopherson, K. S., Ullian, E. M., Stokes, C. C., Mullowney, C. E., Hell, J. W., Agah, A., Lawler, J., Mosher, D. F., Bornstein, P. and Barres, B. A. (2005) Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120, 421-433.
33. Zhang, J. M., Wang, H. K., Ye, C. Q., Ge, W., Chen, Y., Jiang, Z. L., Wu, C. P., Poo, M. M. and Duan, S. (2003) ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 40, 971-982.
34. Marrelli, S. P. (2001) Mechanisms of endothelial P2Y(1)-and P2Y(2)-mediated vasodilatation involve differential [Ca2+]i responses. Am. J. Physiol. Heart Circ. Physiol. 281, H1759-1766.
35. Zonta, M., Angulo, M. C., Gobbo, S., Rosengarten, B., Hossmann, K. A., Pozzan, T. and Carmignoto, G. (2003) Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci. 6, 43-50.
36. Jakovcevic, D. and Harder, D. R. (2007) Role of astrocytes in matching blood flow to neuronal activity. Curr. Top. Dev. Biol. 79, 75-97.
37. Abbott, N. J., Ronnback, L. and Hansson, E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53.
38. Guillemin, G. J. and Brew, B. J. (2004) Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol. 75, 388-397.
39. Zenker, D., Begley, D., Bratzke, H., Rubsamen-Waigmann, H. and von Briesen, H. (2003) Human blood-derived macrophages enhance barrier function of cultured primary bovine and human brain capillary endothelial cells. J. Physiol. 551, 1023-1032.
40. Poritz, L. S., Garver, K. I., Tilberg, A. F. and Koltun, W. A. (2004) Tumor necrosis factor alpha disrupts tight junction assembly. J. Surg. Res. 116, 14-18.
41. Schinkel, A. H. (1999) P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Deliv. Rev. 36, 179-194.
42. Simpson, I. A., Vannucci, S. J., DeJoseph, M. R. and Hawkins, R. A. (2001) Glucose transporter asymmetries in the bovine blood-brain barrier. J. Biol. Chem. 276, 12725-12729.
43. O'Kane, R. L., Martinez-Lopez, I., DeJoseph, M. R., Vina, J. R. and Hawkins, R. A. (1999) Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J. Biol. Chem. 274, 31891-31895.
44. McAllister, M. S., Krizanac-Bengez, L., Macchia, F., Naftalin, R. J., Pedley, K. C., Mayberg, M. R., Marroni, M., Leaman, S., Stanness, K. A. and Janigro, D. (2001) Mechanisms of glucose transport at the blood-brain barrier: an in vitro study. Brain Res. 904, 20-30.
45. Lipton, S. A., Choi, Y. B., Pan, Z. H., Lei, S. Z., Chen, H. S., Sucher, N. J., Loscalzo, J., Singel, D. J. and Stamler, J. S. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626-632.
46. Brown, G. C., Bolanos, J. P., Heales, S. J. and Clark, J. B. (1995) Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci. Lett 193, 201-204.
47. Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. and Chopp, M. (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829-838.
48. Lee, S., Chen, T. T., Barber, C. L., Jordan, M. C., Murdock, J., Desai, S., Ferrara, N., Nagy, A., Roos, K. P. and Iruela-Arispe, M. L. (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130, 691-703.
49. Ruberte, J., Ayuso, E., Navarro, M., Carretero, A., Nacher, V., Haurigot, V., George, M., Llombart, C., Casellas, A., Costa, C., Bosch, A. and Bosch, F. (2004) Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. J. Clin. Invest. 113, 1149-1157.
50. Didier, N., Romero, I. A., Creminon, C., Wijkhuisen, A., Grassi, J. and Mabondzo, A. (2003) Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability. J. Neurochem. 86, 246-254.
51. Massieu, L., Gomez-Roman, N. and Montiel, T. (2000) In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate. Exp. Neurol. 165, 257-267.
52. Lieth, E., Barber, A. J., Xu, B., Dice, C., Ratz, M. J., Tanase, D. and Strother, J. M. (1998) Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 47, 815-820.
53. Barber, A. J., Antonetti, D. A. and Gardner, T. W. (2000) Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest. Ophthalmol. Vis. Sci. 41, 3561-3568.